Pereira A, Shin H, Safdar A, Tobias H, Gelb B, Morgan G, Diflo T, Winnick A, Teperman L. Post Liver Transplant Therapy with Telaprevir For Recurrent Hepatitis C. the American Transplant Congress, the joint annual meeting of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST). Boston, Massachusetts, June 2nd-5th, 2012 American journal of transplantation 2012; 3(SI):430-430.

/in /by

Shin H, Pereira A, Safdar A, Tobias H, Winnick A, Gelb B, Diflo T, Morgan G, Teperman L. Initial Experience of Telaprevir for Recurrent Hepatitis C in Post Liver Transplant Patients. The International Liver Transplantation Society (ILTS) 18th Annual International Congress, May 16-19, 2012, San Francisco, USA [ORAL PRESENTATION] Liver transplantation 2012;18 1 1:S130-S130.

/in /by

Klump SK, Sharp K, Safdar A, Bhardwaj RD, Berens ME, Gilbert BE, Carstens JL, Halpert MM, Spencer DM, Decker WK. Partial Immunovesiculectomy by Th-1 Dendritic Cell Vaccination: Implications for Immunotherapy of Solid Tumors. American Association of Cancer Research Annual Meeting, Chicago, IL March 31-April 4th, 201

/in /by

Klump SK, Sharp K, Safdar A, Bhardwaj RD, Berens ME, Gilbert BE, Carstens JL, Halpert MM, Spencer DM, Decker WK. Immunovesiculectomy by TH1 Dendritic Cell Vaccination. 9th annual Dan L. Duncan Cancer Center Symposium, Baylor College of Medicine, Houston, Texas November 29th, 2011

/in /by

Al Akhrass F, Rodriguez G, Zuniga J, Pande A, Safdar A*. Safety of high-dose (100 mg) caspofungin therapy in 91 cancer and stem cell transplant patients with invasive fungal disease. Abstract # 665. The 48th Annual Meeting of the Infectious Diseases Society of America, October 21–24, 2010 Vancouver, British Columbia, Canada

/in /by

Zuniga J, Rodriguez G, Al Akhrass F, Pande A, Safdar A*. Three hundred and seventy-three granulocyte transfusions in cancer patients with life-threatening infections. Abstract # 1247. The 48th Annual Meeting of the Infectious Diseases Society of America, October 21–24, 2010 Vancouver, British Columbia, Canada

/in /by

Decker WK, Zabriskie R, Gilbert BE, Safdar A. Characterizing surface marker expression and in vivo migration of rHA-loaded dendritic cell vaccines. The 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston September 12-15, 2010

/in /by

Al Akhrass F, Abdallah L, Tarrand J, Raad II, Rolston KV, Safdar A. Antimicrobial susceptibility pattern for 648 clinical Stenotrophomonas maltophilia isolates in patients with cancer between 2008 and 2010. The 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston September 12-15, 2010

/in /by

Decker W, Li S, Shpall E, Zabriskie R, Machado A, Gilbert B, Safdar A*. Dendritic cell vaccination generates protective responses against influenzavirus infection: a model of effective vaccination for immunosuppressed cancer and hematopoietic stem cell transplant patients. The 16thSymposium on Infections in the Immunocompromised Host, Budapest, Hungary June 27-30, 2010

/in /by

Safdar A*, Decker W, Li S, Shpall E, Zabriskie R, Machado A, Gilbert B. Dendritic cell vaccination generates protective responses against influenzavirus infection: a model of effective vaccination for immunosuppressed cancer and hematopoietic stem cell transplant patients. The 13th Annual Conference on Vaccine Research, National Foundation for Infectious Diseases, National Institutes of Health, Bethesda, Maryland April 26th 2010 ORAL PRESENTATION

/in /by